Morning Briefing
Summaries of health policy coverage from major news organizations
Costly Specialty Drugs Drive Up Medicare Tab
ProPublica and The New York Times look at the explosive spending growth related to an obscure medication for treating multiple sclerosis and a rare kidney disease -- and how several top prescribers have links to drugmaker, Questcor Pharmaceuticals. The Wall Street Journal examines the impact of new drugs to treat hepatitis C.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
